328 related articles for article (PubMed ID: 24259725)
1. Clinical epidemiology of carbapenem-resistant enterobacteriaceae in community hospitals: a case-case-control study.
Lee GC; Lawson KA; Burgess DS
Ann Pharmacother; 2013 Sep; 47(9):1115-21. PubMed ID: 24259725
[TBL] [Abstract][Full Text] [Related]
2. Risk factors and outcomes associated with the isolation of polymyxin B and carbapenem-resistant Enterobacteriaceae spp.: A case-control study.
Teo JQ; Chang CW; Leck H; Tang CY; Lee SJ; Cai Y; Ong RT; Koh TH; Tan TT; Kwa AL
Int J Antimicrob Agents; 2019 May; 53(5):657-662. PubMed ID: 30880229
[TBL] [Abstract][Full Text] [Related]
3. Factors Associated to Prevalence and Incidence of Carbapenem-Resistant Enterobacteriaceae Fecal Carriage: A Cohort Study in a Mexican Tertiary Care Hospital.
Torres-Gonzalez P; Cervera-Hernandez ME; Niembro-Ortega MD; Leal-Vega F; Cruz-Hervert LP; García-García L; Galindo-Fraga A; Martinez-Gamboa A; Bobadilla-Del Valle M; Sifuentes-Osornio J; Ponce-de-Leon A
PLoS One; 2015; 10(10):e0139883. PubMed ID: 26431402
[TBL] [Abstract][Full Text] [Related]
4. Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae.
Patel N; Harrington S; Dihmess A; Woo B; Masoud R; Martis P; Fiorenza M; Graffunder E; Evans A; McNutt LA; Lodise TP
J Antimicrob Chemother; 2011 Jul; 66(7):1600-8. PubMed ID: 21508008
[TBL] [Abstract][Full Text] [Related]
5. Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children.
Chiotos K; Tamma PD; Flett KB; Naumann M; Karandikar MV; Bilker WB; Zaoutis T; Han JH
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971864
[TBL] [Abstract][Full Text] [Related]
6. Ertapenem-resistant Enterobacteriaceae: risk factors for acquisition and outcomes.
Hyle EP; Ferraro MJ; Silver M; Lee H; Hooper DC
Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1242-9. PubMed ID: 21029005
[TBL] [Abstract][Full Text] [Related]
7. The epidemiology and risk factor of carbapenem-resistant enterobacteriaceae colonization and infections: Case control study in a single institute in Japan.
Asai N; Sakanashi D; Suematsu H; Kato H; Hagihara M; Nishiyama N; Koizumi Y; Yamagishi Y; Mikamo H
J Infect Chemother; 2018 Jul; 24(7):505-509. PubMed ID: 29548627
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae.
Wu D; Cai J; Liu J
South Med J; 2011 Feb; 104(2):106-10. PubMed ID: 21258230
[TBL] [Abstract][Full Text] [Related]
9. Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).
Goodman KE; Simner PJ; Tamma PD; Milstone AM
Expert Rev Anti Infect Ther; 2016; 14(1):95-108. PubMed ID: 26535959
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity.
Swaminathan M; Sharma S; Poliansky Blash S; Patel G; Banach DB; Phillips M; LaBombardi V; Anderson KF; Kitchel B; Srinivasan A; Calfee DP
Infect Control Hosp Epidemiol; 2013 Aug; 34(8):809-17. PubMed ID: 23838221
[TBL] [Abstract][Full Text] [Related]
11. Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections.
Wang Q; Zhang Y; Yao X; Xian H; Liu Y; Li H; Chen H; Wang X; Wang R; Zhao C; Cao B; Wang H
Eur J Clin Microbiol Infect Dis; 2016 Oct; 35(10):1679-89. PubMed ID: 27401905
[TBL] [Abstract][Full Text] [Related]
12. Statewide surveillance of carbapenem-resistant enterobacteriaceae in Michigan.
Brennan BM; Coyle JR; Marchaim D; Pogue JM; Boehme M; Finks J; Malani AN; VerLee KE; Buckley BO; Mollon N; Sundin DR; Washer LL; Kaye KS
Infect Control Hosp Epidemiol; 2014 Apr; 35(4):342-9. PubMed ID: 24602937
[TBL] [Abstract][Full Text] [Related]
13. Infections due to Carbapenem Resistant Enterobacteriaceae among Saudi Arabian Hospitalized Patients: A Matched Case-Control Study.
Garbati MA; Sakkijha H; Abushaheen A
Biomed Res Int; 2016; 2016():3961684. PubMed ID: 27144165
[TBL] [Abstract][Full Text] [Related]
14. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
Pang F; Jia XQ; Zhao QG; Zhang Y
Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
[TBL] [Abstract][Full Text] [Related]
15. Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected?
Schechner V; Kotlovsky T; Kazma M; Mishali H; Schwartz D; Navon-Venezia S; Schwaber MJ; Carmeli Y
Clin Microbiol Infect; 2013 May; 19(5):451-6. PubMed ID: 22563800
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients exposed to long-term acute care and acute care facilities.
Bhargava A; Hayakawa K; Silverman E; Haider S; Alluri KC; Datla S; Diviti S; Kuchipudi V; Muppavarapu KS; Lephart PR; Marchaim D; Kaye KS
Infect Control Hosp Epidemiol; 2014 Apr; 35(4):398-405. PubMed ID: 24602945
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for the acquisition of carbapenem-resistant Escherichia coli at a tertiary care center in South Korea: a matched case-control study.
Ahn JY; Song JE; Kim MH; Choi H; Kim JK; Ann HW; Kim JH; Jeon Y; Jeong SJ; Kim SB; Ku NS; Han SH; Song YG; Yong D; Lee K; Kim JM; Choi JY
Am J Infect Control; 2014 Jun; 42(6):621-5. PubMed ID: 24837112
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009.
Zilberberg MD; Shorr AF
J Hosp Med; 2013 Oct; 8(10):559-63. PubMed ID: 24022878
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic prescription in intensive care units in Latin America.
Curcio DJ;
Rev Argent Microbiol; 2011; 43(3):203-11. PubMed ID: 22430995
[TBL] [Abstract][Full Text] [Related]
20. Fast and expensive (PCR) or cheap and slow (culture)? A mathematical modelling study to explore screening for carbapenem resistance in UK hospitals.
Knight GM; Dyakova E; Mookerjee S; Davies F; Brannigan ET; Otter JA; Holmes AH
BMC Med; 2018 Aug; 16(1):141. PubMed ID: 30111322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
